converting between glp 1 agonists Switching Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance Approaches for half-life extension of
Description
Tirzepatide: A review in type 2 diabetes

This overlapping approach allows the new medication time to reach therapeutic levels before GLP-1 support is fully withdrawn

Anti-inflammatory effects of GLP-1 in patients with COVID-19

For patients with type 2 diabetes or metabolic syndrome, these metabolic benefits may justify continued treatment even after weight loss goals are met

10.3390/ijms21165722 48 KreymannB.WilliamsG.GhateiM
